Back to publication

Resistance exercise training among young adults with analogue generalized anxiety disorder

Assessed by RV008 · PhD Candidate

Assessed on 16 Nov 2025

OverallReviewer's overall integrity assessment, derived from all research questions No concerns

DOI 10.1016/j.jad.2020.12.020 (opens in new tab)

Resource ripekg:research-integrity-assessment/RIPEA3DBC2655BC9CFDD4

5 Research Questions · 3 Evidence Items

Q1.1 — Does the study have an associated retraction?

Automated Assessment:Assessment produced by the automated systemNo
Human Assessment:Assessment by a domain expert reviewer, informed by AI resultsNo

Rationale: The study linked with some concerns found above is different from the PDF uploaded.

Supporting Evidence (1)

Retraction NoticeSource: Retraction Watch database

Antidepressants for generalised anxiety disorder (GAD)

10.1002/14651858.cd003592.pub2 (opens in new tab)
Journal: Cochrane Database of Systematic ReviewsPublisher: WileyDate: 10 Mar 2016

RetractionWatch ID:Record identifier in the Retraction Watch database 31637

Rationale: Notice - Limited or No Information;Removed

Retracts: Antidepressants for generalized anxiety disorder10.1002/14651858.cd003592 (opens in new tab)

Q1.2 — Does the study have an associated expression of concern or other relevant post-publication notice?

Automated Assessment:Assessment produced by the automated systemNo
Human Assessment:Assessment by a domain expert reviewer, informed by AI resultsNo

Rationale: No rationale provided

Q1.3 — Do other studies by the research team highlight causes for concern?

Automated Assessment:Assessment produced by the automated systemNo
Human Assessment:Assessment by a domain expert reviewer, informed by AI resultsNo

Rationale: No rationale provided

Q2.2 — Are there concerns relating to the timing or absence of study registration?

Automated Assessment:Assessment produced by the automated systemYes
Human Assessment:Assessment by a domain expert reviewer, informed by AI resultsNo

Rationale: No rationale provided

Supporting Evidence (2)

Clinical Trial RegistrationSource: Clinical trial registry (e.g. ClinicalTrials.gov, ISRCTN)

Registration ID: NCT04116944

Registry: ClinicalTrials.gov

Registry Link: https://clinicaltrials.gov/study/NCT04116944 (opens in new tab)

Registration Date: 03-10-2019

Prospective:Whether the trial was registered before participant recruitment began No

Assessment Rationale:How INSPECT-AI determined the prospective registration status by comparing dates Registration date is after LLM recruitment start date.

Study Design EvidenceDates and timelines extracted by INSPECT-AI from the publication text

Recruitment Start: 18-01-2018

Recruitment Start Rationale:INSPECT-AI's reasoning for how it identified the recruitment start date Methods: 'data collection began January 18th, 2018'; assumed this is the recruitment start date.

Recruitment End: N/A

Recruitment End Rationale:INSPECT-AI's reasoning for how it identified the recruitment end date No recruitment end date found after a full document search.

Study End: 26-06-2019

Study End Rationale:INSPECT-AI's reasoning for how it identified the study end date Methods: 'data collection began January 18th, 2018 and concluded June 26th, 2019'; assumed this is the study end date.

Overall — What is the overall integrity assessment of the study?

Automated Assessment:Assessment produced by the automated systemN/A
Human Assessment:Assessment by a domain expert reviewer, informed by AI resultsNo concerns

Rationale: No rationale provided